Senior Consultant Neurosurgeon
Sub-specialty:
Medical Conditions Treated:
Languages:
English, Mandarin, Cantonese, Hokkien
Education:
MBBch, Mmed Surgery (NUS), FRCS (Edinburgh), FRCS (Surgical Neurology) (Edinburgh), FRCS (Surgical Neurology – Intercollegiate Board)(UK), FAMS Neurosurgery
Professional Profile:
Dr Chou Ning has over 20 years of service in the public sector. He is well-versed in various areas of neurosurgery, including trauma, vascular, tumor neurosurgery, pediatric neurosurgery, pituitary surgery, and spinal surgery.
Dr Chou was trained at the Royal London Hospital under the tutelage of Dr. Tom King, a pioneer in the Translabrinthine approach for acoustic neuroma. He has vast experience in managing neurosurgical trauma cases, combined with facial
reconstruction for trauma, and managing primary and secondary brain tumors.
Prof Chou has a particular interest in cerebro-pontine angle and petroclival tumors. He focuses on cyto-reductive surgery with an emphasis on facial nerve preservation for these types of tumors. He has also held the title of Paediatric
Senior Consultant Neurosurgeon at the Paediatric Surgical Centre, NUH, Singapore, and has managed various pediatric tumors ranging from medulloblastoma, craniopharyngioma to low-grade optic nerve-hypothalamic gliomas.
As Clinical Associate Professor of Neurosurgery, he pioneered the rebirth of External Carotid –Internal Carotid Bypass surgery for symptomatic cerebral ischemic patients. In addition, Dr Chou has vast experience in clipping aneurysms involving the anterior cerebral circulation, with strict surgical rules of dissection to ensure clarity of thought for the safety of clipping aneurysms.
Dr Chou is also skilled in pituitary surgery, where he uses the minimally invasive Transphenoidal route. For spine surgery, he has operated on countless cases of degenerative cervical and lumbar spine conditions, myelopathic patients, and
intradural tumors such as schwannomas and meningiomas. He uses gamma knife radiosurgery for deep-seated lesions, as it is a preferred modality of treatment with minimal morbidity and mortality.
© 2025 HealthBridge International Pte Ltd. All rights reserved.
© 2025 HealthBridge International Pte Ltd.
All rights reserved.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |